10-QPeriod: Q2 FY2022

UNITEDHEALTH GROUP INC Quarterly Report for Q2 Ended Jun 30, 2022

Filed August 3, 2022For Securities:UNH

Summary

UnitedHealth Group (UNH) reported strong financial results for the second quarter and first six months of 2022, demonstrating robust revenue growth and improved earnings. Total revenues increased by 13% year-over-year for both the quarter and the six-month period, driven by strong performance across all segments, particularly UnitedHealthcare and Optum. Net earnings attributable to common shareholders saw a significant increase of 19% for the quarter and 11% for the six-month period. The company continues to expand its member base, with UnitedHealthcare adding 1.6 million more people served, driven by growth in Medicare Advantage and Medicaid programs. Optum businesses also showed substantial growth. The company's solid operational performance, coupled with strategic investments and disciplined capital allocation, including increased dividends and share repurchases, positions UNH favorably for continued growth and value creation for shareholders.

Financial Highlights

54 data points
Beta

Revenue

$80.33B

89.3% Gross Margin

Net Income

$5.07B

6.3% Net Margin

EPS (Diluted)

$5.34

Total Assets

$230.17B

Cash & Equivalents

$24.61B

Free Cash Flow

$6.21B

Financial Statements
Beta
Revenue$80.33B
Cost of Revenue$8.60B
Gross Profit$71.74B
SG&A Expenses$11.71B
Operating Expenses$73.20B
Operating Income$7.13B
Interest Expense$467.00M
Net Income$5.07B
EPS (Basic)$5.41
EPS (Diluted)$5.34
Shares Outstanding (Basic)937.00M
Shares Outstanding (Diluted)950.00M

Key Highlights

  • 1Total revenues grew 13% year-over-year to $80.3 billion for the second quarter and $160.5 billion for the first six months of 2022.
  • 2Net earnings attributable to UnitedHealth Group common shareholders increased by 19% to $5.1 billion in Q2 2022 and by 11% to $10.1 billion for the first six months of 2022.
  • 3UnitedHealthcare served 1.6 million more people, primarily driven by growth in Medicare Advantage and Medicaid programs.
  • 4Optum segment revenues grew 18% year-over-year in the second quarter, reflecting broad-based growth across Optum Health, Optum Insight, and Optum Rx.
  • 5Diluted earnings per share (EPS) increased to $5.34 in Q2 2022, a 20% increase compared to $4.46 in Q2 2021.
  • 6Cash flows from operations for the first six months of 2022 were $12.2 billion, up from $11.5 billion in the prior year period.
  • 7The company announced an increase in its quarterly cash dividend to an annual rate of $6.60 per share, a 14% increase from the previous rate.

Frequently Asked Questions

Revenue growth was primarily driven by an increase in the number of people served across Medicare Advantage, Medicaid, and commercial offerings. Growth in pricing trends and robust performance from the Optum businesses, including Optum Health, Optum Insight, and Optum Rx, also significantly contributed to the revenue increase.

Profitability improved significantly, with net earnings attributable to UnitedHealth Group common shareholders rising 19% to $5.1 billion in the second quarter of 2022. Diluted earnings per share (EPS) also saw a strong increase of 20% to $5.34, indicating improved operational efficiency and earnings quality.

The company is actively pursuing strategic growth through business combinations, notably the pending acquisitions of Change Healthcare and LHC Group, requiring approximately $14 billion in capital. They are also focused on organic growth within their Optum and UnitedHealthcare segments, expanding value-based care arrangements and enhancing technology offerings.

UnitedHealth Group maintains a strong liquidity position with $24.6 billion in cash and cash equivalents as of June 30, 2022. They are actively deploying capital through share repurchases ($5 billion for the six months ended June 30, 2022), dividend payments (increased to an annual rate of $6.60 per share), and strategic acquisitions. The company's debt-to-capital ratio remains healthy at approximately 37%.